Circulars and decisions

Circular on General compliance with transportation and storage requirements

Circular organization of the process of obtaining permissions to import veterinary preparations

Circular suspension of registration preparations extended to the people of long-term aerobic

Circular to all pharmaceutical companies on the necessity to issue updated periodic reports on drug safety and marketed drugs

Circulated to all pharmaceutical companies need to send periodic reports to the updated drug safety (PSUR) for marketed drugs

Circulated to all pharmaceutical companies operating in Saudi market the need to identify a person responsible for vigilance and medication safety

Circulated to inform the pharmacovigilance center

Circulating on the modernization of corporate data in the system of Sidr (new)

Circulation for Current linear Drug Bar-coding development to 2D (Datamatrix

Compliance with SFDA.FD 783 “Instant Coffee”

Contingency plans to reduce the risks of using formula (EXJADE ® (Deferasirox

Cough and cold medications should not be used for infants and children <6 years of age